To address this key question, and in the absence of publicly available RNA‐seq data on HD and CP‐CML CD34+CD15− cells, we evaluated the transcriptional status of PB CD34+ cells to identify candidate genes the expression of which could be affected by aberrant DNA methylation of their promoter in CP‐CML CD34+CD15− cells. Here, CD34 is linked to Huntington disease.